This report aims to provide a comprehensive presentation of the global market for Anti-infectious Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-infectious Disease Drugs. This report contains market size and forecasts of Anti-infectious Disease Drugs in global, including the following market information:
Global Anti-infectious Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-infectious Disease Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-infectious Disease Drugs companies in 2022 (%)
The global Anti-infectious Disease Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antibacterial Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-infectious Disease Drugs include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd, Beijing Double-Crane Pharmaceutical Co., Ltd., Abbott, Spero Therapeutics, Adlyfe, Inc. and Advanced Life Sciences Holdings, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-infectious Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-infectious Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs
Global Anti-infectious Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Institute of Medicine
Clinic
Others
Global Anti-infectious Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-infectious Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-infectious Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-infectious Disease Drugs revenues share in global market, 2022 (%)
Key companies Anti-infectious Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-infectious Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-infectious Disease Drugs, market overview.
Chapter 2: Global Anti-infectious Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-infectious Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-infectious Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-infectious Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-infectious Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-infectious Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-infectious Disease Drugs Overall Market Size
2.1 Global Anti-infectious Disease Drugs Market Size: 2022 VS 2029
2.2 Global Anti-infectious Disease Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-infectious Disease Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-infectious Disease Drugs Players in Global Market
3.2 Top Global Anti-infectious Disease Drugs Companies Ranked by Revenue
3.3 Global Anti-infectious Disease Drugs Revenue by Companies
3.4 Global Anti-infectious Disease Drugs Sales by Companies
3.5 Global Anti-infectious Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-infectious Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-infectious Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-infectious Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-infectious Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-infectious Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-infectious Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 Antibacterial Drugs
4.1.3 Antifungal Drugs
4.1.4 Antiviral Drugs
4.1.5 Antiparasitic Drugs
4.2 By Type - Global Anti-infectious Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-infectious Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-infectious Disease Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Anti-infectious Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Anti-infectious Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Anti-infectious Disease Drugs Sales, 2024-2029
4.3.3 By Type - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Anti-infectious Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-infectious Disease Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Institute of Medicine
5.1.4 Clinic
5.1.5 Others
5.2 By Application - Global Anti-infectious Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-infectious Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-infectious Disease Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Anti-infectious Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Anti-infectious Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Anti-infectious Disease Drugs Sales, 2024-2029
5.3.3 By Application - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Anti-infectious Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-infectious Disease Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-infectious Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-infectious Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-infectious Disease Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Anti-infectious Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Anti-infectious Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Anti-infectious Disease Drugs Sales, 2024-2029
6.3.3 By Region - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Anti-infectious Disease Drugs Revenue, 2018-2029
6.4.2 By Country - North America Anti-infectious Disease Drugs Sales, 2018-2029
6.4.3 US Anti-infectious Disease Drugs Market Size, 2018-2029
6.4.4 Canada Anti-infectious Disease Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-infectious Disease Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Anti-infectious Disease Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Anti-infectious Disease Drugs Sales, 2018-2029
6.5.3 Germany Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.4 France Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.6 Italy Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.7 Russia Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-infectious Disease Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-infectious Disease Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Anti-infectious Disease Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Anti-infectious Disease Drugs Sales, 2018-2029
6.6.3 China Anti-infectious Disease Drugs Market Size, 2018-2029
6.6.4 Japan Anti-infectious Disease Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-infectious Disease Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-infectious Disease Drugs Market Size, 2018-2029
6.6.7 India Anti-infectious Disease Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Anti-infectious Disease Drugs Revenue, 2018-2029
6.7.2 By Country - South America Anti-infectious Disease Drugs Sales, 2018-2029
6.7.3 Brazil Anti-infectious Disease Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-infectious Disease Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, 2018-2029
6.8.3 Turkey Anti-infectious Disease Drugs Market Size, 2018-2029
6.8.4 Israel Anti-infectious Disease Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-infectious Disease Drugs Market Size, 2018-2029
6.8.6 UAE Anti-infectious Disease Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Aridis Pharmaceuticals
7.1.1 Aridis Pharmaceuticals Company Summary
7.1.2 Aridis Pharmaceuticals Business Overview
7.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Aridis Pharmaceuticals Key News & Latest Developments
7.2 AiCuris
7.2.1 AiCuris Company Summary
7.2.2 AiCuris Business Overview
7.2.3 AiCuris Anti-infectious Disease Drugs Major Product Offerings
7.2.4 AiCuris Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AiCuris Key News & Latest Developments
7.3 Sandoz
7.3.1 Sandoz Company Summary
7.3.2 Sandoz Business Overview
7.3.3 Sandoz Anti-infectious Disease Drugs Major Product Offerings
7.3.4 Sandoz Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sandoz Key News & Latest Developments
7.4 Anhui Jingfang Medical Industry Co.,Ltd
7.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Summary
7.4.2 Anhui Jingfang Medical Industry Co.,Ltd Business Overview
7.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Major Product Offerings
7.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Anhui Jingfang Medical Industry Co.,Ltd Key News & Latest Developments
7.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
7.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Summary
7.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Business Overview
7.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Major Product Offerings
7.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Anti-infectious Disease Drugs Major Product Offerings
7.6.4 Abbott Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Spero Therapeutics
7.7.1 Spero Therapeutics Company Summary
7.7.2 Spero Therapeutics Business Overview
7.7.3 Spero Therapeutics Anti-infectious Disease Drugs Major Product Offerings
7.7.4 Spero Therapeutics Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Spero Therapeutics Key News & Latest Developments
7.8 Adlyfe, Inc.
7.8.1 Adlyfe, Inc. Company Summary
7.8.2 Adlyfe, Inc. Business Overview
7.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Adlyfe, Inc. Key News & Latest Developments
7.9 Advanced Life Sciences Holdings, Inc.
7.9.1 Advanced Life Sciences Holdings, Inc. Company Summary
7.9.2 Advanced Life Sciences Holdings, Inc. Business Overview
7.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Advanced Life Sciences Holdings, Inc. Key News & Latest Developments
7.10 Affinium Pharmaceuticals
7.10.1 Affinium Pharmaceuticals Company Summary
7.10.2 Affinium Pharmaceuticals Business Overview
7.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Affinium Pharmaceuticals Key News & Latest Developments
7.11 APP Pharmaceuticals
7.11.1 APP Pharmaceuticals Company Summary
7.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Business Overview
7.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Major Product Offerings
7.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.11.5 APP Pharmaceuticals Key News & Latest Developments
7.12 Aquapharm Biodiscovery
7.12.1 Aquapharm Biodiscovery Company Summary
7.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Business Overview
7.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Major Product Offerings
7.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Aquapharm Biodiscovery Key News & Latest Developments
7.13 Basilea Pharmaceutica AG
7.13.1 Basilea Pharmaceutica AG Company Summary
7.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Business Overview
7.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Major Product Offerings
7.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Basilea Pharmaceutica AG Key News & Latest Developments
7.14 Biophage Pharma, Inc.
7.14.1 Biophage Pharma, Inc. Company Summary
7.14.2 Biophage Pharma, Inc. Business Overview
7.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Major Product Offerings
7.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Biophage Pharma, Inc. Key News & Latest Developments
8 Global Anti-infectious Disease Drugs Production Capacity, Analysis
8.1 Global Anti-infectious Disease Drugs Production Capacity, 2018-2029
8.2 Anti-infectious Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-infectious Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-infectious Disease Drugs Supply Chain Analysis
10.1 Anti-infectious Disease Drugs Industry Value Chain
10.2 Anti-infectious Disease Drugs Upstream Market
10.3 Anti-infectious Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-infectious Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Anti-infectious Disease Drugs in Global Market
Table 2. Top Anti-infectious Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-infectious Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-infectious Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-infectious Disease Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-infectious Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-infectious Disease Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Anti-infectious Disease Drugs Product Type
Table 9. List of Global Tier 1 Anti-infectious Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-infectious Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-infectious Disease Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-infectious Disease Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-infectious Disease Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-infectious Disease Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-infectious Disease Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-infectious Disease Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-infectious Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-infectious Disease Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-infectious Disease Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-infectious Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-infectious Disease Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales, (K Units), 2024-2029
Table 46. Aridis Pharmaceuticals Company Summary
Table 47. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 48. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Aridis Pharmaceuticals Key News & Latest Developments
Table 50. AiCuris Company Summary
Table 51. AiCuris Anti-infectious Disease Drugs Product Offerings
Table 52. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AiCuris Key News & Latest Developments
Table 54. Sandoz Company Summary
Table 55. Sandoz Anti-infectious Disease Drugs Product Offerings
Table 56. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sandoz Key News & Latest Developments
Table 58. Anhui Jingfang Medical Industry Co.,Ltd Company Summary
Table 59. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offerings
Table 60. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Anhui Jingfang Medical Industry Co.,Ltd Key News & Latest Developments
Table 62. Beijing Double-Crane Pharmaceutical Co., Ltd. Company Summary
Table 63. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offerings
Table 64. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Beijing Double-Crane Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Anti-infectious Disease Drugs Product Offerings
Table 68. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Abbott Key News & Latest Developments
Table 70. Spero Therapeutics Company Summary
Table 71. Spero Therapeutics Anti-infectious Disease Drugs Product Offerings
Table 72. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Spero Therapeutics Key News & Latest Developments
Table 74. Adlyfe, Inc. Company Summary
Table 75. Adlyfe, Inc. Anti-infectious Disease Drugs Product Offerings
Table 76. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Adlyfe, Inc. Key News & Latest Developments
Table 78. Advanced Life Sciences Holdings, Inc. Company Summary
Table 79. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offerings
Table 80. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Advanced Life Sciences Holdings, Inc. Key News & Latest Developments
Table 82. Affinium Pharmaceuticals Company Summary
Table 83. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 84. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Affinium Pharmaceuticals Key News & Latest Developments
Table 86. APP Pharmaceuticals Company Summary
Table 87. APP Pharmaceuticals Anti-infectious Disease Drugs Product Offerings
Table 88. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. APP Pharmaceuticals Key News & Latest Developments
Table 90. Aquapharm Biodiscovery Company Summary
Table 91. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offerings
Table 92. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Aquapharm Biodiscovery Key News & Latest Developments
Table 94. Basilea Pharmaceutica AG Company Summary
Table 95. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offerings
Table 96. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Basilea Pharmaceutica AG Key News & Latest Developments
Table 98. Biophage Pharma, Inc. Company Summary
Table 99. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offerings
Table 100. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Biophage Pharma, Inc. Key News & Latest Developments
Table 102. Anti-infectious Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Anti-infectious Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Anti-infectious Disease Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Anti-infectious Disease Drugs Production by Region, 2024-2029 (K Units)
Table 106. Anti-infectious Disease Drugs Market Opportunities & Trends in Global Market
Table 107. Anti-infectious Disease Drugs Market Drivers in Global Market
Table 108. Anti-infectious Disease Drugs Market Restraints in Global Market
Table 109. Anti-infectious Disease Drugs Raw Materials
Table 110. Anti-infectious Disease Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Anti-infectious Disease Drugs Downstream
Table 112. Anti-infectious Disease Drugs Downstream Clients in Global Market
Table 113. Anti-infectious Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-infectious Disease Drugs Segment by Type in 2022
Figure 2. Anti-infectious Disease Drugs Segment by Application in 2022
Figure 3. Global Anti-infectious Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-infectious Disease Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-infectious Disease Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-infectious Disease Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-infectious Disease Drugs Revenue in 2022
Figure 9. By Type - Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-infectious Disease Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-infectious Disease Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Anti-infectious Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-infectious Disease Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-infectious Disease Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-infectious Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-infectious Disease Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-infectious Disease Drugs by Region, 2022 VS 2029
Figure 54. Anti-infectious Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
